MALACRIDA, ALESSIO

MALACRIDA, ALESSIO  

DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)  

Mostra records
Risultati 1 - 20 di 45 (tempo di esecuzione: 0.019 secondi).
Titolo Tipologia Data di pubblicazione Autori File
Insight Into Chemotherapeutic-Agents-Induced-Neuroinflammation In Rat Experimental Neuropathies 02 - Intervento a convegno 2024 Meregalli ,CChiorazzi, AArgentini, ABallarini, ElisaCanta, ACarozzi VMalacrida, AMarmiroli, PTarasiuk, OCavaletti, G
Neurodegeneration: can metabolites from Eremurus persicus help? 01 - Articolo su rivista 2024 Malacrida A.Miloso M. +
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 02 - Intervento a convegno 2024 Malacrida, ATarasiuk, ONicolini, GCavaletti, GMeregalli, C +
The Role of NMNAT2/SARM1 in Neuropathy Development 01 - Articolo su rivista 2024 Tarasiuk, OMolteni, LMalacrida, ANicolini, G
Another Brick to Confirm the Efficacy of Rigosertib as Anticancer Agent 01 - Articolo su rivista 2023 Malacrida A.Rigolio R.Cavaletti G.Miloso M. +
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 02 - Intervento a convegno 2023 Meregalli, CMalacrida, ANicolini, GCavaletti, G +
Paclitaxel, but Not Cisplatin, Affects Satellite Glial Cells in Dorsal Root Ganglia of Rats with Chemotherapy-Induced Peripheral Neurotoxicity 01 - Articolo su rivista 2023 Pozzi, EBallarini, ERodriguez Menendez, VCanta, AChiorazzi, AMonza, LBossi, MAlberti, PMalacrida, AMeregalli, CScuteri, ACavaletti, GCarozzi, V
Potential in-vitro antiviral activity of MV1035 on SARS-CoV-2 wild type viruses 01 - Articolo su rivista 2023 Malacrida, AlessioNicolini, Gabriella +
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 02 - Intervento a convegno 2022 Semperboni, SMalacrida, AMonza, LNicolini, GCavaletti GMeregalli C +
Evaluation of antitumoral effect of Hibiscus sabdariffa extract on human breast cancer cells 01 - Articolo su rivista 2022 Malacrida A.Hashemi M.Rodriguez-Menendez V.Cavaletti G.Miloso M. +
From Nature to Synthetic Compounds: Novel 1(N),2,3 Trisubstituted-5-oxopyrrolidines Targeting Multiple Myeloma Cells 01 - Articolo su rivista 2022 Malacrida, AlessioCavaletti, GuidoMiloso, Mariarosaria +
Morphological and functional assessment of NCX2 potential role in axonal damage related to Oxaliplatin 02 - Intervento a convegno 2022 Alberti, PBallarini, EMalacrida, APozzi, EMonza, LChiorazzi, ACanta, ANicolini, GScuteri, AMarmiroli, PCavaletti, G +
MV1035 Overcomes Temozolomide Resistance in Patient-Derived Glioblastoma Stem Cell Lines 01 - Articolo su rivista 2022 Malacrida, ADi Domizio, ABentivegna, AMessuti, EGiussani, CNicolini, G +
NCX2 modulation to prevent axonal damage related to Oxaliplatin-induced peripheral neurotoxicity 02 - Intervento a convegno 2022 Alberti, PBallarini, EMalacrida, APozzi, EMonza, LChiorazzi, ACanta, ANicolini, GScuteri, AMarmiroli, PCavaletti, G +
Rigosertib and cholangiocarcinoma: A cell cycle affair 01 - Articolo su rivista 2022 Malacrida A.Cavaletti G.Miloso M.
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 01 - Articolo su rivista 2022 Ballarini, EMalacrida, ARodriguez Menendez, VPozzi, ECanta, AChiorazzi, AMonza, LSemperboni, SMeregalli, CCarozzi, VHashemi, MNicolini, GScuteri, ACavaletti, GAlberti, P +
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa—part 2 01 - Articolo su rivista 2021 Malacrida A.Rigolio R.Miloso M. +
In vitro evaluation of rigosertib antitumoral and radiosensitizing effects against human cholangiocarcinoma cells 01 - Articolo su rivista 2021 Malacrida A.Rigolio R.Cavaletti G.Miloso M. +
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 02 - Intervento a convegno 2021 Semperboni, SMalacrida, AMonza, LNicolini GCavaletti, GMeregalli, C +
INVESTIGATING THE INVOLVEMENT OF SATELLITE GLIAL CELLS IN PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY 02 - Intervento a convegno 2021 Pozzi,EBallarini, ERodriguez Menendez, VAlberti, PCanta, AMonza, LMalacrida, AScuteri, ACavaletti, GCarozzi, VA